Berlin Cures' failed Long COVID clinical trial yields lessons on study design

BC 007, a German infusion drug that targets autoantibodies, is heading for new study. Graphic showing the top of Berlin's TV Tower, edited to look ...


View article...


Top stories of the last 30 days